Showing results (1851-1860 of 1,960) with videos related to

Sort By:
Pageof 196
Blood Cancer Journal|July 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphomaJanek S Walker, Kerstin Wenzl, Joseph P Novak, et al.
Blood Advances|January 11, 2024
Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapyJessica F Burlile, Kelsey M Frechette, William G Breen, et al.
Blood Cancer Journal|October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomasMelissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
Neuro-Oncology|July 9, 2018
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trialAndrew B Lassman, Martin J van den Bent, Hui K Gan, et al.
Blood|February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin LymphomaCatherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Research Involvement and Engagement|July 19, 2022
Standardised data on initiatives-STARDIT: Beta versionJack S Nunn, Thomas Shafee, Steven Chang, et al.
Blood Advances|July 19, 2024
Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapyOmran Saifi, William G Breen, Scott C Lester, et al.
The Journal of Clinical Investigation|August 3, 2026
TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivoShahrzad Jalali, Sekar Natesampillai, Zilin Nie, et al.
The Lancet. Oncology|February 25, 2018
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohortsSarah Huet, Bruno Tesson, Jean-Philippe Jais, et al.
Blood Advances|December 3, 2025
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific WorkshopReid W Merryman, Sarah C Rutherford, Stephen M Ansell, et al.
Pageof 196